# Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

> **NCT03961971** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 16 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** MBG453

## Key facts

- **NCT ID:** NCT03961971
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-18
- **Primary completion:** 2022-11-16
- **Final completion:** 2026-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961971, "Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03961971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*